CellSeed (TSE:7776) Other Current Payables: 円190.26 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:7776 CellSeed Inc TSE:7776
55 GF Score
Price 円219.00
GF Value 円161.95
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is CellSeed Other Current Payables?

CellSeed TSE:7776 -2.23% 55 Other Current Payables is 円190.26 Mil as of Dec. 2025. GuruFocus rates TSE:7776 with a GF Score™ of 55/100 and a GF Value™ of 円161.95 (Significantly Overvalued). The stock has 4 warning signs investors should review.

CellSeed's Other Current Payables for the quarter that ended in Dec. 2025 was 円190.26 Mil.

CellSeed's quarterly Other Current Payables declined from Jun. 2025 (円202.71 Mil) to Sep. 2025 (円150.22 Mil) but then increased from Sep. 2025 (円150.22 Mil) to Dec. 2025 (円190.26 Mil).

CellSeed's annual Other Current Payables declined from Dec. 2023 (円73.51 Mil) to Dec. 2024 (円43.69 Mil) but then increased from Dec. 2024 (円43.69 Mil) to Dec. 2025 (円190.26 Mil).

CellSeed Other Current Payables Related Terms

CellSeed Other Current Payables Historical Data

* Premium members only.

The historical data trend for CellSeed's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CellSeed Other Current Payables Chart

CellSeed Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 80.74 29.50 73.51 43.69 190.26

CellSeed Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 261.79 202.71 150.22 190.26 168.93
TSE:7776
55GF Score
CellSeed Inc TSE:7776
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CellSeed Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of 円190.26 Mil mean?
CellSeed (TSE:7776) has a Other Current Payables of 円190.26 Mil as of Dec. 2025. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on CellSeed and its competitors.
Is CellSeed's Other Current Payables too high?
CellSeed's current Other Current Payables is 円190.26 Mil. Overall, CellSeed has a GF Score™ of 55/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does CellSeed's Other Current Payables compare to VRTX and REGN?
CellSeed's Other Current Payables of 円190.26 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Biotechnology company?
A good Other Current Payables depends on the Biotechnology industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on CellSeed and its competitors. CellSeed's current Other Current Payables is 円190.26 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CellSeed stock overvalued right now?
Based on GuruFocus' analysis, CellSeed (TSE:7776) is currently considered Significantly Overvalued. The stock's GF Value™ is 円161.95, compared to a current price of 円219.00 — trading 35.2% above its estimated fair value. The current Other Current Payables is 円190.26 Mil. CellSeed's overall GF Score™ is 55/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For CellSeed (TSE:7776), the current Other Current Payables is 円190.26 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CellSeed (TSE:7776) Overvalued in 2026?

Based on GuruFocus' analysis, CellSeed stock appears to be overvalued. The current stock price of 円219.00 is trading 35.2% above its estimated GF Value™ of 円161.95. GuruFocus considers CellSeed to be Significantly Overvalued.

Key valuation signals for TSE:7776:

  • Other Current Payables: 円190.26 Mil
  • GF Value™: 円161.95 vs. price of 円219.00 (35.2% above fair value)
  • GF Score™: 55/100 with 4 warning signs

No single metric tells the full story. See the TSE:7776 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CellSeed Business Description

Address 2-5-10 Aomi, Telecom Center Building, 15th Floor (East Wing, Koto-ku, Tokyo, JPN, 135-0064
CellSeed Inc is a Japanese biotechnology company. The company is involved in the research, development, marketing, and sale of cell-sheet regenerative medicines, such as epithelial cell sheets for corneal and esophageal regeneration; regenerated cardiac patches to treat heart diseases; cell sheets for periodontal tissue regeneration; and regenerated cartilage sheets for the treatment of osteoarthritis.
55GF Score

Get the complete analysis for TSE:7776

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円219.00
Price
円161.95
GF Value